Global Markets for Drug Repurposing

  • ID: 3634273
  • Report
  • Region: Global
  • 103 Pages
  • BCC Research
15 % OFF
until Dec 31st 2018
1 of 6
The Global Market for Drug Repurposing Will Grow from Nearly $24.4 Billion in 2015 to Nearly $31.3 Billion by 2020

FEATURED COMPANIES

  • Abbvie Inc.
  • Aurobindo Pharma Ltd.
  • Celgene Corp.
  • Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Par Pharmaceutical Inc.
  • MORE
This report provides an overview of the current and future global market for drug repurposing. Includes forecast through 2020.

This report provides:

- An overview of the global markets for drug re-purposing, (also known as re-positioning or re-profiling) referring to studies about a compound or a biologic agent that treats one condition and sees if that particular compound is safe and effective for treating other diseases.
- Analyses of U.S. as well as international market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- A look at how human intervention and investigation early in the drug discovery process is helping in faster development of therapeutics.
- Evaluation of drug-repurposing compared to traditional drug development where cost and the time for the drug to be available in the market is greatly reduced since the re-purposed drug has already passed a significant number of tests.
- Coverage of how the discovery process for repurposing drugs has accelerated in recent years due to the emergence of new tools and technologies.
- Profiles of major players in the industry.

Use this report to:

- Analyze the global market for repurposed drugs by application, by usage, and used orally or intravenously.
- Analyze the various trends, mergers and acquisitions within the repurposed drug market.
- Gain information about the regulatory environment, technologies, market projections and market shares for repurposed drug market.
- Gain information about the usage of repurposed drugs in central nervous disorders, cardiovascular disorders, oncology, metabolic, autoimmune, and other disorders.

Reasons For Doing The Study:

The development of a completely new drug or entity takes an immense amount of time, money and effort, mainly due to a prolonged therapeutic development process. Drug repurposing represents a new hope in the drug discovery process. Extensive research into drug repurposing has revealed how therapeutic treatments for various diseases can be provided in cost-effective ways.

Modern industries have now begun to explore the advantages of drug repurposing in their production and research processes. The market’s growth is influenced by the advancements, new product launches and the changing lifestyles of customers. This study looks at almost all the systems affected by these factors.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each new technology and the competitors in the market, as well as changing customer needs.

Intended Audience:

This study’s look at the areas of market growth in repurposed drugs manufacturers and users will prove to be of interest to pharmaceutical company, biotechnological companies, research institutes and physicians.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbvie Inc.
  • Aurobindo Pharma Ltd.
  • Celgene Corp.
  • Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Par Pharmaceutical Inc.
  • MORE
Chapter 1: Introduction
- Study Goals And Objectives
- Reasons For Doing The Study
- Intended Audience
- Scope Of The Report
- Methodology
- Information Sources
- Analyst's Credentials
- Disclaimer

Chapter 2: Executive Summary

Chapter 3: Overview
- Definitions
- Pharmaceutical Drugs
- Classification Of Drugs
- Drug Development Process
- Drug Repurposing
- Development Of Repurposed Drugs
- Drug Repurposing Methods
- Application Areas Of Drug Repurposing
- Advantages And Limitations Of Drug Repurposing
- Common Repositioned Drugs

Chapter 4: Regulatory Aspects
- Recalls
- Safety Alerts

Chapter 5: Trends
- Drug Repositioning In Pipeline
- Mergers And Acquisitions
- Current Situation
- Factors Affecting Drug Repurposing
- Market Opportunities

Chapter 6: Market Analysis
- Introduction
- Market By Region
- Market By Application
- Market Analysis By Usage
- Market Analysis By Application Site

Chapter 7: Industry Structure
- Central Nervous System Disorders
- Autoimmune Disorders
- Oncology Disorders
- Cardiovascular Disorders
- Metabolic Disorders
- Other Disorders

Chapter 8: Patent Analysis
- Patents By Year
- Patents By Company
- Patents By Country
- Patents By Assignee

Chapter 9: Company Profiles
- Abbvie Inc.
- Actavis Inc.
- Alexion Pharmaceuticals Inc.
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Biogen Idec Inc.
- Biovista Inc.
- Celgene Corp.
- Dr. Reddy's Laboratories Ltd.
- Eli Lilly & Co.
- Glaxosmithkline
- Hoffmann-La Roche Ag
- Hospira Inc.
- Jenken Biosciences Inc.
- Johnson & Johnson
- Melior Pharmaceuticals Inc
- Merck & Co. Inc.
- Mylan Pharmaceuticals Inc.
- Novartis Ag
- Par Pharmaceutical Inc.
- Pfizer Inc.
- Sandoz
- Sanofi
- Som Biotech Sl
- Sosei Group Ltd.
- Takeda Pharmaceuticals U.S.A. Inc.
- Teva Pharmaceutical Industries Ltd.
- Ucb
- Zydus Cadila Group

Chapter 10: Appendix I: Abbreviations

List Of Tables

- Summary Table : Global Market For Repurposed Drugs By Region, Through 2020
- Table 1 : Comparison Of Chemically Synthesized Drugs And Biologic Drugs
- Table 2 : Evolution Of Drug Products
- Table 3 : Differences In Novel Drug Development And Drug Repurposing
- Table 4 : Common Repositioned Drugs That Are Market Approved Or Undergoing Research
- Table 5 : Market Approvals Of Repurposed Drugs, 2010 To April 2015
- Table 6 : Recalls Of Repurposed Drugs, 2010 To April 2015
- Table 7 : Safety Alerts For Repurposed Drugs
- Table 8 : Mergers And Acquisitions Of Major Pharmaceutical Companies, 2010 To April 2015
- Table 9 : Global Market For Repurposed Drugs By Region, Through 2020
- Table 10 : Global Market Shares Of Repurposed Drugs By Region, 2014
- Table 11 : Global Market For Repurposed Drugs By Application, Through 2020
- Table 12 : Global Market Shares Of Repurposed Drugs By Application, 2014
- Table 13 : Types Of Central Nervous System Disorders
- Table 14 : Global Market For Repurposed Drugs Used For Central Nervous System Disorders By Region, Through 2020
- Table 15 : Types Of Cardiovascular Disorders
- Table 16 : Global Market For Repurposed Drugs Used For Cardiovascular Disorders By Region, Through 2020
- Table 17 : Types Of Cancer-Depending On The Tissue Of Origin
- Table 18 : Global Market For Repurposed Drugs Used For Oncology Disorders By Region, Through 2020
- Table 19 : Types Of Autoimmune Diseases
- Table 20 : Global Market For Repurposed Drugs Used For Autoimmune Disorders By Region, Through 2020
- Table 21 : Global Market For Repurposed Drugs Used For Metabolic And Other Disorders By Region, Through 2020
- Table 22 : Global Market For Repurposed Drugs By Usage, Through 2020
- Table 23 : Global Market For Repurposed Drugs By Application Site Through 2020
- Table 24 : Leading Manufacturers/Suppliers Of Repurposed Drugs For Central Nervous System Disorders, 2014
- Table 25 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Central Nervous System Disorders, 2014
- Table 26 : Leading Manufacturers/Suppliers Of Repurposed Drugs For Autoimmune Disorders, 2014
- Table 27 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Autoimmune Disorders, 2014
- Table 28 : Leading Manufacturers/Suppliers Of Repurposed Drugs For Oncology Disorders, 2014
- Table 29 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Oncology, 2014
- Table 30 : Leading Manufacturers/Suppliers Of Repurposed Drugs For Cardiovascular Disorders, 2014
- Table 31 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Cardiovascular Disorders, 2014
- Table 32 : Leading Manufactures/Suppliers Of Repurposed Drugs For Metabolic Disorders, 2014
- Table 33 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Metabolic Disorders, 2014
- Table 34 : Leading Manufacturers/Suppliers Of Repurposed Drugs For Other Disorders, 2014
- Table 35 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Other Disorders, 2014
- Table 36 : Number Of Patents By Year, 2010 To April 2015
- Table 37 : Number Of Patents By Company, 2010 To April 2015
- Table 38 : Number Of Patents By Country, 2010 To April 2015
- Table 39 : Patents By Country, 2010 To April 2015
- Table 40 : Number Of Patents By Assignee Type, 2010 To April 2015

List Of Figures

- Summary Figure : Global Market Trends For Repurposed Drugs By Region, 2013-2020
- Figure 1 : Global Market Trends For Repurposed Drugs By Region, 2013-2020
- Figure 2 : Global Market Shares Of Repurposed Drugs By Region, 2014
- Figure 3 : Global Market Trends For Repurposed Drugs By Application, 2013-2020
- Figure 4 : Global Market Shares Of Repurposed Drugs By Application, 2014
- Figure 5 : Global Market Trends For Repurposed Drugs Used For Central Nervous System Disorders By Region, 2013-2020
- Figure 6 : Global Market Trends For Repurposed Drugs Used For Cardiovascular Disorders By Region, 2013-2020
- Figure 7 : Global Market Trends For Repurposed Drugs Used For Oncology Disorders By Region 2013-2020
- Figure 8 : Global Market Trends For Repurposed Drugs Used For Autoimmune Disorders By Region, 2013-2020
- Figure 9 : Global Market For Repurposed Drugs Used For Metabolic And Other Disorders By Region, 2013-2020
- Figure 10 : Global Market For Repurposed Drugs By Usage, 2013-2020
- Figure 11 : Global Market Trends For Repurposed Drugs By Application Site 2013-2020
- Figure 12 : Market Shares Of Manufacturers/ Suppliers Of Repurposed Drugs For Central Nervous System Disorders, 2014
- Figure 13 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Autoimmune Disorders, 2014
- Figure 14 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Oncology, 2014
- Figure 15 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Cardiovascular Disorders, 2014
- Figure 16 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Metabolic Disorders, 2014
- Figure 17 : Market Shares Of Manufacturers/Suppliers Of Repurposed Drugs For Other Disorders, 2014
- Figure 18 : Number Of Patents By Year, 2010 To April 2015
- Figure 19 : Number Of Patents By Company, 2010 To April 2015
- Figure 20 : Number Of Patents By Country, 2010 To April 2015
- Figure 21 : Patent Shares By Country, 2010 To April 2015
- Figure 22 : Number Of Patents By Assignee Type, 2010 To April 2015
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbvie Inc.
  • Aurobindo Pharma Ltd.
  • Celgene Corp.
  • Hoffmann-La Roche Ag
  • Johnson & Johnson
  • Par Pharmaceutical Inc.
  • MORE
Study Goals And Objectives:

Drug repurposing is the one of the major revolutions taking place in the pharmaceutical industry. Advancements in technologies such as bioinformatics, genomics and proteomics are making drug repositioning possible. Drug repositioning/repurposing reduces development costs and time, improves return on investment and also facilitates the rescue of previously failed compounds.

Our goal in conducting this study is to provide an overview of the current and future global market for drug repurposing. The key objective is to present a comprehensive analysis and outline the future direction of drug repurposing as an important change in the process of drug development. The report discusses market improvements, setbacks and demands and compares the use of this type of development.

Through a detailed analysis of the structure of the drug repurposing industry, the revenues have been broken down intoU.S.and non-U.S. sectors. Sales figures are estimated for the five-year period from 2015 through 2020. Applications for drug repurposing are also discussed, with an emphasis on the use of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and their allotments in each category.

Scope Of The Report:

This report provides a global overview of drug repurposing, also known as repositioning or reprofiling, including the techniques and applications in various therapies. The report deals with the global market for repurposed drugs in three main areas: market by application of repurposed drugs, by usage of repurposed drugs and by application site (i.e., whether they are used orally or intravenously). The application area is divided into types of disorders (i.e., repurposed drugs in central nervous disorders, cardiovascular disorders, oncology, metabolic, autoimmune and other disorders).

Market by usage is analyzed on the basis that repurposed drugs are used alone in single therapy or used in combination with other drugs. Excluded from this report are drugs that are not yet approved as repurposed drugs. We analyzed the market and its applications, regulatory environment, technologies involved, market projections and market shares. The market is mainly divided into theU.S.and the rest of the world (ROW).

Also included in the report are relevant patent analysis and comprehensive profiles of the leading companies in the drug repurposing market. The key players are Novartis AG, Abbott Healthcare, Pfizer Inc., Johnson & Johnson and Hoffmann-La Roche. Other significant players are the generic drug manufacturers such as Sandoz, Mylan Inc., and Teva Pharmaceuticals. The chapter on company profiles also includes even core drug repurposing companies such as SOM Biotech, Biovista Inc. and Sosei Group Ltd.
Note: Product cover images may vary from those shown
5 of 6
- Abbvie Inc.
- Actavis Inc.
- Alexion Pharmaceuticals Inc.
- Apotex Inc.
- Aurobindo Pharma Ltd.
- Biogen Idec Inc.
- Biovista Inc.
- Celgene Corp.
- Dr. Reddy's Laboratories Ltd.
- Eli Lilly & Co.
- Glaxosmithkline
- Hoffmann-La Roche Ag
- Hospira Inc.
- Jenken Biosciences Inc.
- Johnson & Johnson
- Melior Pharmaceuticals Inc
- Merck & Co. Inc.
- Mylan Pharmaceuticals Inc.
- Novartis Ag
- Par Pharmaceutical Inc.
- Pfizer Inc.
- Sandoz
- Sanofi
- Som Biotech Sl
- Sosei Group Ltd.
- Takeda Pharmaceuticals U.S.A. Inc.
- Teva Pharmaceutical Industries Ltd.
- Ucb
- Zydus Cadila Group
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll